The study on the entrapment efficiency and in vitro release of puerarin submicron emulsion

AAPS PharmSciTech

Volumn 10, Issue 2, 2009, Pages 376-383

  Yue, Peng Fei ^a,b   Lu, Xiu Yun ^a   Zhang, Zeng Zhu ^c   Yuan, Hai Long ^d   Zhu, Wei Feng ^a   Zheng, Qin ^b   Yang, Ming ^b  

^a JIANGXI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c The 94th Hospital of PLA   (China)

^d BEIJING 302 HOSPITAL   (China)

Author keywords

Drug release; Entrapment efficiency; Microdialysis; Pressure ultrafiltration technology; Submicron emulsion

Indexed keywords

LIPOSOME; PUERARIN; ISOFLAVONE DERIVATIVE; MICROSPHERE;

ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG FORMULATION; DRUG RELEASE; DRUG STRUCTURE; EMULSION; IN VITRO STUDY; INTERMETHOD COMPARISON; PARTICLE SIZE; PROCESS TECHNOLOGY; REACTION TIME; ULTRACENTRIFUGATION; ULTRAFILTRATION; CHEMISTRY; MICELLE; MICRODIALYSIS; MICROSCOPY; SOLUBILITY;

EMULSIONS; ISOFLAVONES; LIPOSOMES; MICELLES; MICRODIALYSIS; MICROSCOPY; MICROSPHERES; PARTICLE SIZE; SOLUBILITY; ULTRAFILTRATION;

EID: 67549101328     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-009-9216-3     Document Type: Article

References (36)

1. Kawakami S, Yamashita F, Hasida M. Disposition characteristics of emulsion and incorporated drugs after systemic or local injection. Adv Drug Deliv Rev. 2000;45:77-88.
2. Nasirideen S. Naproxen incorporated lipid emulsion fomulation and stability study. J Clin Pharm Ther. 1998;23:57-65.
3. Mizushima Y, Shoji Y, Kato T, Fukushima M, Kurozumi S. Use of lipid microspheres as a drug carrier for antitumour drugs. J Pharm Pharmacol. 1986;38:132-4.
4. Venkataram S, Awini WM, Jordan K, Rahman YE. Pharmacokinetics of two alternative dosage forms for cyclosporine: Liposomes and intralipid. J Pharm Sci. 1990;79:216-9.
5. Forster D, Washington C, Davis SS. Toxicity of solubilized and colloidal amphotericin B formulations to human erythrocytes. J Pharm Pharmacol. 1988;40:325-8.
6. Fukui H, Koike T, Saheki A, Sonoke S, Seki J. A novel delivery system for amphotericin B with lipid nanosphere. Int J Pharm. 2003;265:37-45.
7. 1 in lipid emulsions. Adv Drug Deliv Rev. 1996;20:155-64.
8. Menashe YL, Levy L, Shoshanna GS, Benita S. Side effect evaluation of a new diazepam formulation: Venous sequela reduction following intravenous injection of a diazepam emulsion in rabbits. Pharm Res. 1989;6:510-6.
9. López-Pinto JM, González-Rodríguez ML, Rabasco AM. Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes. Int J Pharm. 2005;298:1-12.
10. Patel VB, Misra AN. Encapsulation and stability of clofazimine liposomes. J Microencapsul. 1999;16:357-67.
11. Patlolla RR, Vobalaboina V. Pharmacokinetics and tissue distribution of etoposide delivered in parenteral emulsion. J Pharm Sci. 2005;94:437-45.
12. Cui FD, Shi K, Zhang L, Tao AJ, Kawashima YJ. Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: Preparation, in vitro characterization and in vivo evaluation. J Control Release. 2006;114:242-50.
13. Wang T, Deng YJ, Geng YH, Gao ZB, Zou JP, Wang ZX. Progress of study on niosomes. Biochim Biophys Acta. 2006;1758:222-31.
14. Michalowski CB, Guterres SS, Dalla Costa T. Microdialysis for evaluating the entrapment and release of a lipophilic drug from nanoparticles. J Pharm Biomed Anal. 2004;35:1093-100.
15. Han J, Washington C. Partition of antimicrobial additives in an intravenous emulsion and their effect on emulsion physical stability. Int J Pharm. 2005;288:263-71.
16. Liu Q, Lu Z, Wang L. Restrictive effect of puerarin on myocardial infarct area in dogs and its possible mechanism. J Tongji Med Univ. 2000;20:43-5.
17. Guerra MC, Speroni E, Broccoli M, et al. Comparison between Chinese medical herb Pueraria lobata crude extract and its main isoflavone puerarin: Antioxidant properties and effects on rat liver CYP-catalysed drug metabolism. Life Sci. 2000;67:2997-3006.
18. Lu XR, Gao E, Xu LZ, Li HZ, Kang B, Chen WN, Chen SM, Chai XS. Puerarin beta-adrenergic receptor blocking effect. Chin Med J. 1987;100:25-8.
19. Liao HB, He ZF, Wang GC, Li HJ, Yue CJ, Chen XF. Research progress about Radix puerariae. Sci Technol Food Ind. 2003;24:81-2.
20. Fan LL, Sun LH. The protective effect of puerarin against myocardial reperfusion injury. Chin Med J. 1992;105:7-11.
21. Xuan B, Zhou YH, Yang RL. Improvement of ocular blood flow and retinal functions with puerarin analogs. J Ocul Pharmacol Ther. 1999;15:207-16.
22. Zhang LN, Shi HQ. Analysis on 60 cases of pueraria injection adverse reactions. Chinese Journal of Drug Application and Monitoring 2004;3:1672-73.
23. Yue PF, Yang HL, Yang M, Zhu WF, Cai PL, Xiao XH. The study to reduce the hemolysis side effect of puerarin by a submicron emulsion delivery system. Biol Pharmaceut Bull. 2008;31:45-50.
24. Zhang Y. Studies on physicochemical of crystal fiavonoids by polymorphism of puerarin. Hefei University of Technology Dissertation 2003;72:43-5.
25. Lu B, Wu W. Optimization of preparation of dexamethasone acetate-loaded poly(d,l -lactide) microspheres by central composite design. Acta Pharmaceutica Sinica 1999;34:387-91.
26. Hansen DK, Davies MI, Lunte SM, Lunte CE. Pharmacokinetic and metabolism studies using microdialysis sampling. J Pharm Sci. 1999;88:14-27.
27. Li Y, Pan WS, Chen SL, Yang DJ, et al. Studies on preparation of puerarin phytosomes and their solid dispersion. Chinese Pharmaceutical Journal 2006;41:1162-7.
28. Chambrier C, Guriraud M, Gibault JP. Medium and long-chain triacglycerols in postoperatice patients: Structured lipid versus a physical mixture. Nutrition 1999;15:274-77.
29. Wang LX, He HB, Tang X, Shao RY, Chen DW. A less irritant norcantharidin lipid microspheres: Formulation and drug distribution. Int J Pharm. 2006;323:161-7.
30. Groves MJ, Wineberg M, Brain APR. The presence of liposomal material in phosphatide stabilized emulsions. J Dispers Sci Technol. 1985;2:237-43.
31. Uchegbu IF, Vyas SP. Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm. 1998;172:33-70.
32. Férézou J, Lai NT, Leray C, Hajri T, Frey A, Cabaret Y, Courtieu J. Lipid composition and structure of commercial parenteral emulsions. Biochim Biophys Acta. 1994;1213:149-58.
33. Bach A, Férézou J, Frey A. Phospholipid-rich particles in commercial parenteral fat emulsions. Prog Lipid Res. 1996;35:133-53.
34. Herrera AM, Scott DO, Lunte CE. Microdialysis sampling for determination of plasma protein binding of drugs. Pharm Res. 1990;7:1077-81.
35. Magenheim B, Levy MY, Benita S. A new in vitro technique for the evaluation of drug release profile from colloidal carriers by ultrafiltration technique at low pressure. Int J Pharm. 1993;94:115-23.
36. Benita S, Levy MY. Submicron emulsions as colloidal drug carriers for intravenous administration: Comprehensive physicochemical characterization. J Pharm Sci. 1993;82:1069-79.